Zantac Cancer Victims Hurry To Register And Comply With Time Limitations

More than 100,000 Zantac lawsuits are expected to be filed accusing Sanofi of fraud and negligence in failing to warns them of Zantac's cancer side effect

Friday, August 20, 2021 - Individuals that have developed cancer and have taken Zantac ranitidine, the world's best-selling brand of heartburn relief and antacid, have filed around 700 lawsuits. That number could go significantly higher since 100 times that many people have filed a census form, registering their intent to sue the manufacturer of the medicine with the courts. People have filed to go on record and time stamp their claim for purposes of complying with the statute of limitations that governs their claim. People must have used the Zantac brand no more than ten years before their cancer diagnosis and must file within four years of the cancer diagnosis. People who register to file push back the statute of limitations and have more time. Generic manufacturers and retailers of ranitidine are exempt from Zantac cancer lawsuits by an order from the judge presiding over the cases in multidistrict litigation. All forms of ranitidine were recalled and banned in the United States by the FDA when they were informed by a private online testing laboratory that they have discovered levels of carcinogenic NDMA at levels thought to be dangerous to human health. People who wish to join the lawsuit and file a viable claim must prove they purchased the medicine by providing financial records and bank statements. Successfully plaintiffs will also provide medical records that show a cancer diagnosis and treatment. Surviving loved ones of those who have died allegedly from taking Zantac ranitidine should also present the death certificate.

One way in which Zantac plaintiffs are similar to one another is that they have been prescribed Zantac ranitidine or purchased it over the counter at their local drug store. Another way is that plaintiffs claim the acid reflux drug causes cancer, and suffer from one or more types allegedly from using Zantac. For more than 20 years, Sanofi, the manufacturers of Zantac, earned billions of dollars in sales from over 15 million customers at any one time. People that took Zantac have developed various types of cancer such as stomach, bladder, esophagus, colon, and prostate cancer, and others. Plaintiffs say they purchased and took Zantac on their doctor's recommendation, and had they known of the risks they would have chosen another antacid medicine. The US Department of Justice thinks Sanofi lied to the FDA about having no knowledge that ranitidine degrades to form N-nitrosodimethylamine (NDMA), a deadly carcinogen previously used to induce cancer tumors in laboratory animals in the US. If you or a deceased loved one has taken Zantac thinking it was safe and instead developed cancer, you should speak with a Zantac cancer lawyer and fill out the census form to potentially file a claim. Zantac plaintiffs seek reimbursement of medical expenses past and future, reimbursement of lost wages due to their sickness past and future, and significant, lump-sum punitive damages.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.